CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS: CNBX · Delayed Price · USD
0.0200
-0.0011 (-5.21%)
May 30, 2023, 11:11 AM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.11 | 0 | 0 | 0 | |
| Revenue Growth (YoY) | - | - | -27.29% | 2.53% | 69.01% | -94.95% | - | - | - | - | |
| Gross Profit | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Selling & Marketing | 0.02 | 0.02 | 0.06 | 0.29 | 0.42 | 0.29 | 0 | 0.06 | 0 | 0 | |
| General & Administrative | 1.75 | 0.81 | 1.31 | 1.48 | 2.39 | 1.33 | 0.21 | 0.33 | 0.21 | 0.06 | |
| Research & Development | 1.18 | 1.77 | 1.68 | 1.54 | 1 | 0.25 | 0.18 | 0.14 | 0 | 0 | |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -0 | 0 | -0 | 0.01 | 0 | 0 | |
| Operating Expenses | 2.95 | 2.6 | 3.05 | 3.31 | 3.82 | 1.86 | 0.39 | 0.54 | 0.22 | 0.06 | |
| Operating Income | -2.95 | -2.6 | -3.04 | -3.3 | -3.81 | -1.85 | -0.28 | -0.54 | -0.22 | -0.06 | |
| Interest Expense | 0 | 0 | 0.01 | 0.02 | 0 | 0 | 0.01 | 0 | 0 | 0 | |
| Other Expense / Income | 0.77 | 0.59 | 4.42 | -4.45 | -0.03 | 0.08 | 0.02 | -0 | 0.05 | 0 | |
| Pretax Income | -3.72 | -3.19 | -7.47 | 1.13 | -3.78 | -1.93 | -0.31 | -0.54 | -0.22 | -0.06 | |
| Income Tax | 0.05 | -0.17 | -0.01 | -4.44 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Income | -3.77 | -3.02 | -7.46 | 5.57 | -3.78 | -1.93 | -0.31 | -0.54 | -0.27 | -0.06 | |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 120 | 110 | 103 | 101 | 100 | 1 | |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 120 | 110 | 103 | 101 | 100 | 1 | |
| Shares Change | 5.92% | 2.95% | 1.59% | -99.08% | 9.06% | 6.90% | 2.53% | 0.46% | 7269.12% | 0.00% | |
| EPS (Basic) | -3.08 | -2.62 | -6.65 | 5.05 | -0.03 | -0.02 | -0.00 | -0.01 | -0.00 | -0.04 | |
| EPS (Diluted) | -3.08 | -2.62 | -6.65 | 5.05 | -0.03 | -0.02 | -0.00 | -0.01 | -0.00 | -0.04 | |
| Free Cash Flow Per Share | -1.37 | -2.16 | -2.54 | -3.00 | -0.02 | -0.01 | -0.00 | -0.00 | -0.00 | -0.02 | |
| Gross Margin | - | - | 100.00% | 100.00% | - | - | - | - | - | - | |
| Operating Margin | - | - | -42524.12% | -33563.01% | -39674.25% | -32639.05% | -249.49% | - | - | - | |
| Profit Margin | - | - | -104238.40% | 56570.89% | -39339.79% | -34046.48% | -273.05% | - | - | - | |
| Free Cash Flow Margin | - | - | -39830.98% | -33634.70% | -30386.31% | -17417.99% | -106.76% | - | - | - | |
| Effective Tax Rate | - | - | - | -391.48% | - | - | - | - | - | - | |
| EBITDA | -3.48 | -3.15 | -7.25 | -3.1 | -3.69 | -1.92 | -0.3 | -0.54 | -0.27 | -0.06 | |
| EBITDA Margin | - | - | -101317.54% | -31444.24% | -38409.67% | -33845.92% | -265.27% | - | - | - | |
| Depreciation & Amortization | 0.2 | 0.22 | 0.22 | 0.19 | 0.09 | 0.01 | 0 | 0 | 0 | 0 | |
| EBIT | -3.68 | -3.37 | -7.47 | -3.28 | -3.78 | -1.93 | -0.3 | -0.54 | -0.27 | - | |
| EBIT Margin | - | - | -104323.75% | -33363.66% | -39330.92% | -33969.49% | -266.67% | - | - | - |
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.